Timeline

24 Apr 2018

publication

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors

20 Dec 2016

publication

Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate

30 Sep 2015

project

A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human

28 May 2014

publication

CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus

20 Feb 2014

publication

Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings

10 Jan 2013

publication

Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses

01 Apr 2011

publication

Regulatory B cells control dendritic cell functions

30 Dec 2010

publication

Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses

18 Aug 2010

publication

Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant

12 Nov 2009

publication

Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils

01 Apr 2009

publication

Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide

15 Sep 2008

publication

Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines

10 Jul 2008

publication

Regulatory B and T cells in infections

07 May 2007

publication

Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells

16 Aug 2006

publication

Fetal spleen stroma drives macrophage commitment

31 Jan 2006

publication

Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination

01 Apr 2005

publication

Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs

01 Jul 2004

publication

Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen

01 Feb 2003

publication

The shift of Th1 to Th2 immunodominance associated with the chronicity of Mycobacterium bovis bacille Calmette-Guérin infection does not affect the memory response

01 Mar 2002

publication

A little guide for advanced search:

Timeline

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors

Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate

A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human

CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus

Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings

Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses

Regulatory B cells control dendritic cell functions

Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses

Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant

Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils

Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide

Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines

Regulatory B and T cells in infections

Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells

Fetal spleen stroma drives macrophage commitment

Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination

Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs

Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen

The shift of Th1 to Th2 immunodominance associated with the chronicity of Mycobacterium bovis bacille Calmette-Guérin infection does not affect the memory response

Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells